SG11201502292WA - Method for producing extended-release potassium citrate wax matrix tablet - Google Patents

Method for producing extended-release potassium citrate wax matrix tablet

Info

Publication number
SG11201502292WA
SG11201502292WA SG11201502292WA SG11201502292WA SG11201502292WA SG 11201502292W A SG11201502292W A SG 11201502292WA SG 11201502292W A SG11201502292W A SG 11201502292WA SG 11201502292W A SG11201502292W A SG 11201502292WA SG 11201502292W A SG11201502292W A SG 11201502292WA
Authority
SG
Singapore
Prior art keywords
potassium citrate
matrix tablet
wax matrix
release potassium
producing extended
Prior art date
Application number
SG11201502292WA
Inventor
Wendell G Mendoza
Rita Josefina M Santos
Eulogio C Singh
Kennie U Dee
Original Assignee
Wendell G Mendoza
Rita Josefina M Santos
Eulogio C Singh
Kennie U Dee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wendell G Mendoza, Rita Josefina M Santos, Eulogio C Singh, Kennie U Dee filed Critical Wendell G Mendoza
Publication of SG11201502292WA publication Critical patent/SG11201502292WA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/889Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2068Compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Inorganic Chemistry (AREA)
SG11201502292WA 2012-09-27 2012-09-27 Method for producing extended-release potassium citrate wax matrix tablet SG11201502292WA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/PH2012/000013 WO2014051443A1 (en) 2012-09-27 2012-09-27 Method for producing extended-release potassium citrate wax matrix tablet

Publications (1)

Publication Number Publication Date
SG11201502292WA true SG11201502292WA (en) 2015-04-29

Family

ID=50388700

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201502292WA SG11201502292WA (en) 2012-09-27 2012-09-27 Method for producing extended-release potassium citrate wax matrix tablet

Country Status (10)

Country Link
US (1) US11033627B2 (en)
EP (1) EP2900222B1 (en)
JP (1) JP6150148B2 (en)
KR (1) KR101812090B1 (en)
CN (1) CN104661653B (en)
ES (1) ES2639547T3 (en)
HK (1) HK1210722A1 (en)
PH (1) PH12015500467A1 (en)
SG (1) SG11201502292WA (en)
WO (1) WO2014051443A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2640022T3 (en) 2013-02-28 2017-10-31 United Laboratories, Inc. High dose extended release potassium citrate wax matrix tablet
WO2016159897A1 (en) 2015-04-01 2016-10-06 Ay Doğan Potassium citrate suspension
WO2016159898A1 (en) 2015-04-01 2016-10-06 Ay Doğan Slow release composition comprising potassium citrate and magnesium citrate
KR102274835B1 (en) * 2019-06-17 2021-07-08 주식회사 한국팜비오 A sustained-release tablet comprising a potassium citrate composition
KR102490581B1 (en) 2020-10-30 2023-01-20 운해이엔씨(주) Quantum energy generator equipped with discharge function for gas, liquid and fluid treatment

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1658062A (en) * 1926-03-15 1928-02-07 United Shoe Machinery Corp Carnauba wax and the preparation thereof
US4966776A (en) * 1983-04-11 1990-10-30 Board Of Regents, The University Of Texas System Compositions and methods of treating calcium renal stones
ZA882783B (en) * 1987-06-10 1988-10-20 Warner-Lambert Company Process for preparing a pharmaceutical composition
JPH03232814A (en) * 1990-02-08 1991-10-16 Shin Etsu Chem Co Ltd Production of sustained release tablet
NZ270439A (en) * 1995-02-02 1996-04-26 Bernard Charles Sherman Solid slow release pharmaceutical composition: carrier is polyethylene glycol and hydrophilic gel-forming polymer
JP5026630B2 (en) * 2000-03-31 2012-09-12 小林製薬株式会社 Granulated powder, method for producing the same and compression molded solid
RU2007143556A (en) * 2005-04-25 2009-06-10 ТЕВА ФАРМАСЬЮТИКАЛЗ ЮЭсЭй, ИНК. (US) PROLONGED RELEASE COMPOSITIONS
US20080131504A1 (en) * 2006-12-01 2008-06-05 Mission Pharmacal Co. Short Term Slow Release Drug Delivery System
CN102240272B (en) * 2010-05-13 2013-07-10 丽珠医药集团股份有限公司 Potassium citrate sustained release tablet and preparation method thereof
CN102488670B (en) * 2011-12-22 2013-05-01 苏州东瑞制药有限公司 Preparation method of dual slow-release potassium citrate sustained release preparation

Also Published As

Publication number Publication date
KR20150074003A (en) 2015-07-01
ES2639547T3 (en) 2017-10-27
US11033627B2 (en) 2021-06-15
PH12015500467B1 (en) 2015-04-20
EP2900222A4 (en) 2016-03-16
CN104661653A (en) 2015-05-27
JP2015531370A (en) 2015-11-02
JP6150148B2 (en) 2017-06-21
EP2900222A1 (en) 2015-08-05
EP2900222B1 (en) 2017-06-14
PH12015500467A1 (en) 2015-04-20
WO2014051443A1 (en) 2014-04-03
KR101812090B1 (en) 2017-12-27
HK1210722A1 (en) 2016-05-06
US20150231267A1 (en) 2015-08-20
CN104661653B (en) 2017-07-14

Similar Documents

Publication Publication Date Title
HK1260333A1 (en) Magnesium alloy, method for the production thereof and use thereof
GB2514071B (en) Shape memory alloy actuation apparatus
HK1200881A1 (en) Magnesium alloy, method for the production thereof and use thereof
SG11201406026TA (en) Magnesium-zinc-calcium alloy, method for production thereof, and use thereof
ZA201209124B (en) Process for producing microcapsules
GB2489658B (en) Tablet press
EP2933034A4 (en) Press forming method
SG11201503318PA (en) Method for microcontact embossing
SG11201504465TA (en) Ruthenium complex, method for producing same, and method for producing ruthenium-containing thin film
PT2757876E (en) Phytoseiid predatory mite releasing system and method for production.
EP2857001A4 (en) Method for producing tablet, and tablet
HK1210722A1 (en) Method for producing extended-release potassium citrate wax matrix tablet
EP2840156A4 (en) Magnesium alloy and method for producing same
EP2837619A4 (en) Method for producing beta -alkoxypropionamide
IL237075A0 (en) Method for producing hexahydrofurofuranol derivative
ZA201400326B (en) Bouillon tablet process
EP2835437A4 (en) Magnesium alloy, magnesium alloy member and method for manufacturing same, and method for using magnesium alloy
IL238755A0 (en) Method for producing carboxamides
EP2937406A4 (en) Method for manufacturing briquette
EP2824130A4 (en) Method for producing polydialkylsilane
ZA201500438B (en) Method for producing microcarriers
EP2719377A4 (en) Method for producing orodispersible tablets
EP2811029A4 (en) Method for producing scyllo-inositol
IL219622A (en) Continuous process for obtaining microcapsules
SG11201501567QA (en) Method for producing 7-octenal